Back to News
Market Impact: 0.25
Trump Administration Working on More Drug Pricing Deals, Oz Says
Source: Bloomberg
Healthcare & BiotechRegulation & Legislation
CMS Administrator Mehmet Oz said the Trump administration is pursuing additional drug-pricing deals with pharmaceutical companies. No companies, pricing terms, expected savings, or implementation timeline were disclosed, limiting the immediate read-through for individual drugmakers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Pharvaris at Wells Fargo conference: oral HAE drug gains ground
- Nano-X Imaging (NNOX) Q2 2026 Earnings Call Transcript
- Chewy (CHWY) Q2 2026 Earnings Call Transcript
- Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights
- Justice Department probes Nvidia’s Groq deal over antitrust concerns
- RNC Day 1 Kicks off in Dallas